Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026)
Stoke Therapeutics' quarterly Prepaid Assets came in at $10.1 million in Q1 2026, down 20.32% year-on-year from $12.7 million in Q1 2025, and up 130.46% quarter-over-quarter from $4.4 million in Q4 2025.
Stoke Therapeutics has reported Prepaid Assets for 9 years, with the latest figure at $10.1 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 20.32% year-over-year to $10.1 million; the trailing twelve-month figure through Mar 2026 stood at $10.1 million (down 20.32% YoY), and the FY2025 full-year result was $4.4 million, up 91.08% from the prior year.
- Prepaid Assets for Q1 2026 stood at $10.1 million, up from $4.4 million in the prior quarter.
- The five-year high for Prepaid Assets was $13.2 million in Q2 2022, with the low at $2.3 million in Q4 2024.
- Average Prepaid Assets over 5 years is $7.8 million, with a median of $7.7 million recorded in 2025.
- Year-over-year, Prepaid Assets slumped 71.93% in 2023 and surged 91.08% in 2025.
- Tracing STOK's Prepaid Assets over 5 years: stood at $3.0 million in 2022, then retreated by 13.33% to $2.6 million in 2023, then declined by 10.31% to $2.3 million in 2024, then surged by 91.08% to $4.4 million in 2025, then surged by 130.46% to $10.1 million in 2026.
- The last three Prepaid Assets figures came in at $10.1 million (Q1 2026), $4.4 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.12 Mn |
| Dec 31, 2025 | 4.39 Mn |
| Sep 30, 2025 | 7.75 Mn |
| Jun 30, 2025 | 6.87 Mn |
| Mar 31, 2025 | 12.69 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 10.72 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Sep 30, 2023 | 10.94 Mn |
| Jun 30, 2023 | 3.70 Mn |
| Mar 31, 2023 | 5.88 Mn |
| Dec 31, 2022 | 2.96 Mn |
| Sep 30, 2022 | 12.55 Mn |
| Jun 30, 2022 | 13.18 Mn |
| Mar 31, 2022 | 12.29 Mn |
| Dec 31, 2021 | 2.22 Mn |
| Sep 30, 2021 | 8.47 Mn |
| Jun 30, 2021 | 8.61 Mn |
| Mar 31, 2021 | 7.51 Mn |
| Dec 31, 2020 | 6.44 Mn |
| Sep 30, 2020 | 3.62 Mn |
| Jun 30, 2020 | 3.53 Mn |
| Mar 31, 2020 | 4.34 Mn |
| Dec 31, 2019 | 3.28 Mn |
| Sep 30, 2019 | 3.26 Mn |
| Jun 30, 2019 | 1.51 Mn |
| Dec 31, 2018 | 548,000.00 |